Skip to content
    Deerfield Management logo

    Deerfield Management

    New York, New York, United StatesFounded 1994

    Deerfield Management Company is a New York-based investment firm founded in 1994, dedicated to advancing healthcare through investment, intelligence, and philanthropy. It makes public and private investments across the healthcare and biotechnology industries and is considered one of the largest dedicated healthcare investment firms in the world.

    39% of their portfolio is in Biotech & Life Sciences. Deal activity decreased year-over-year (5 deals in the last 12 months vs 14 prior). Average disclosed round size is $80.8M (across 194 rounds with reported amounts).

    Find people at Deerfield Management on Goldilocks AI

    Portfolio

    147

    Fund Size

    $600M

    Top Stage

    Series C

    Last 12 Mo

    5

    Team

    JF

    Jim Flynn

    Managing Partner

    AA

    Alexander Ashavsky

    Managing Director, Data Science and Engineering

    DG

    Daniel Glass

    Managing Director, Global Market Research

    JA

    Jared Anderman

    Managing Director, Data Analytics

    MB

    Michael Bergen

    Managing Director

    SA

    Stephen Anastos

    Managing Director

    AD

    Anne Daub

    Partner

    JI

    Jonathan Isler

    Partner and Chief Financial Officer, Funds

    JL

    Jonathan Leff

    Partner

    KH

    Karen Heidelberger

    Partner and Chief Partnerships Officer

    LA

    Lawrence Atinsky

    Partner

    LH

    Leslie Henshaw

    Partner

    Portfolio Breakdown

    Stage Distribution

    Sector Distribution

    Investment Activity

    DealsAvg Round Size

    Portfolio

    210 investments
    CompanyRoundAmountDate
    Terns Pharmaceuticals logoTerns PharmaceuticalsSeries C$87MMay 2026
    Ray Therapeutics logoRay TherapeuticsSeries B$125MApr 2026
    Neomorph logoNeomorphSeries B$100MApr 2026
    SHINE logoSHINEGrowth$240MFeb 2026
    Regenxbio logoRegenxbioSeries C$30MJan 2026
    SHINE Technologies logoSHINE TechnologiesUnknown$240MJan 2026
    myLaurel logomyLaurelSeed—Nov 2025
    Axon logoAxonSeries A$32MSep 2025
    AAxon VascularSeries A$32MSep 2025
    BBridgeBio Oncology TherapeuticsUnknown$261MAug 2025
    Actio Biosciences logoActio BiosciencesSeries B$66MJun 2025
    myLaurel logomyLaurelSeries A$12MJun 2025
    AAtlas Data StorageSeed$155MMay 2025
    Ascertain logoAscertainSeries A$10MApr 2025
    Perceive Bio logoPerceive BioSeries A$15MFeb 2025
    NNema HealthSeries A$14.5MJan 2025
    Nema logoNemaSeries A$14.5MJan 2025
    Reprieve Cardiovascular logoReprieve CardiovascularSeries B$61MJan 2025
    Pleno logoPlenoSeries A$40MDec 2024
    Pleno logoPlenoSeries B$25MDec 2024
    Lomond Therapeutics logoLomond TherapeuticsSeries B$44MNov 2024
    Petfolk logoPetfolkSeries C$36MOct 2024
    Pairwise logoPairwiseSeries C$40MSep 2024
    iRhythm Technologies logoiRhythm TechnologiesDebt$200MSep 2024
    SpectraWAVE logoSpectraWAVESeries B$50MSep 2024
    Page 1 of 9

    Top Co-Investors

    Last updated: 20 October 2026